HIV trials recruiting in Ohio

All HIV trials nationally

Cities in Ohio

Recruiting trials in Ohio

• A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
  NCT07266831 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Columbus
• A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
  NCT05719441 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Ohio: Cincinnati, Cleveland, Columbus
• A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
  NCT07202546 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Cincinnati
• A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
  NCT04139304 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Columbus
• A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
  NCT07650916 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · Ohio: Columbus
• Augmented Renal Clearance in Neurocritical Care
  NCT07410624 · Phase: Not specified · Ages: 18 Years to 85 Years · Sex: All (male and female) · Ohio: Columbus
• Dasatinib for HIV-1 Reservoir Reduction
  NCT07342491 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Cleveland
• Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1
  NCT06071767 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Columbus
• Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
  NCT05077527 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Columbus
• Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
  NCT04949464 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years to 80 Years · Sex: All (male and female) · Ohio: Columbus
• Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
  NCT07473778 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Cincinnati, Columbus
• Menopausal HT for Women Living With HIV (HoT)
  NCT06856174 · Phase: Phase 4 · Ages: 40 Years to 60 Years · Sex: Female · Ohio: Cincinnati, Cleveland, Columbus
• Positive Peers Intervention Clinical Trial
  NCT06388109 · Phase: Not applicable (e.g. observational or device study) · Ages: 13 Years to 34 Years · Sex: All (male and female) · Ohio: Cincinnati, Columbus
• Screen Smart: Using Digital Health to Improve HIV Screening and Prevention
  NCT06003192 · Phase: Not applicable (e.g. observational or device study) · Ages: 15 Years to 21 Years · Sex: All (male and female) · Ohio: Columbus
• Small Trial of Alendronate Impact on the Reservoir of HIV
  NCT07216794 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Ohio: Columbus
• Study of GS-0415 and How It Works in People With HIV
  NCT07719491 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Ohio: Columbus